Clinical trial
Pre- and Postoperative Incidence and Prognostic Implication of Positive Peritoneal Lavage and Circulating Tumor DNA in Patients With Pancreatic Cancer
NCT05400681 is registered in ClinicalTrials.gov with Sonke Detlefsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pre- and Postoperative Incidence and Prognostic Implication of Positive Peritoneal Lavage and Circulating Tumor DNA in Patients With Pancreatic Cancer
- Lead sponsor
- Sonke Detlefsen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2020
- Completion date
- December 31, 2024
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic adenocarcinoma, pancreatic cancer